U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944924) titled 'Endoscopic Ultrasound Predictors of Malignancy in IPMNs: Toward Personalized, Data-driven Risk Stratification' on April 07.

Brief Summary: Intraductal papillary mucinous neoplasms (IPMNs) are among the most clinically relevant pancreatic cystic lesions because of their potential for malignant transformation into high-grade dysplasia or invasive carcinoma. Accurate preoperative risk stratification is essential to identify patients who may benefit from surgical resection while avoiding unnecessary surgery in those with low-grade disease.

Endoscopic ultrasound (EUS) plays a central role in the evaluation of IPMNs because it allows det...